Asensus Surgical Announces Franklin Medical Center to Initiate the Installation of the Senhance Surgical System
November 15 2021 - 6:55AM
Business Wire
Franklin Medical Center to become 4th Senhance
Hospital in Louisiana
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
the patient to pioneer a new era of Performance-Guided Surgery™,
today announced the Franklin Medical Center in Winnsboro, Louisiana
has entered into an agreement to lease and utilize a Senhance®
Surgical System.
“We are excited to bring the Senhance system's unique
capabilities to yet another innovative hospital in the United
States,” said Anthony Fernando, Asensus Surgical President and CEO.
“We are particularly enthusiastic to see hospitals in the United
States leveraging the capabilities of the ISU™. With features such
as precise real-time intraoperative measurements and digital tags,
the ISU’s intraoperative intelligence sets Senhance apart from
other current and future robotic systems.”
Asensus Surgical's technology platform, Senhance Surgical
System, is the first of its kind digital laparoscopic platform that
leverages augmented intelligence to provide unmatched performance
and patient outcomes through machine learning. Senhance goes beyond
the typical surgical robotic systems, providing surgical assurance
through haptic feedback, eye-tracking camera control, and 3D
visualization, and is the first platform to offer 3 mm instruments
(the smallest instrument available in the world on a robotic
surgical platform). The Senhance Surgical System is powered by the
Intelligent Surgical Unit™ (ISU). The ISU enables machine
vision-driven control of the camera for a surgeon by responding to
commands and recognizing certain objects and locations in the
surgical field, and allows a surgeon to change the visualized field
of view using the movement of their instruments.
“Prior to our adoption of Senhance, we avoided adding a soft
tissue robotics platform to our general surgery department because
of a lack of meaningful benefits offered to our surgeons and
patients by competing platforms. That has changed with Senhance and
the platform’s innovative intelligent capabilities and laparoscopic
foundation,” said Dr. David Gutierrez, Chief of General Surgery at
Franklin Medical Center. “Senhance adds a new dynamic to soft
tissue abdominal robotics, one that we believe will improve our
surgical outcomes, reduce the burden of recovery placed upon our
patients, and allows us to bring the highest quality of care to all
those we serve.”
About Franklin Medical Center
Franklin Medical Center is an acute-care hospital in Winnsboro,
Louisiana serving Franklin, Tensas, and Catahoula Parishes in
Louisiana. Franklin Medical Center has been a part of Franklin
Parish since 1970. The hospital has provided healthcare to this
area of Louisiana for over 50 years.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking clinical intelligence for surgeons to enable
consistently superior outcomes and a new standard of surgery. This
builds upon the foundation of Digital Laparoscopy with the Senhance
Surgical System powered by the Intelligent Surgical Unit (ISU) to
increase surgeon control and reduce surgical variability. With the
addition of machine vision, augmented intelligence, and deep
learning capabilities throughout the surgical experience, we intend
to holistically address the current clinical, cognitive and
economic shortcomings that drive surgical outcomes and value-based
healthcare. Learn more about Performance-Guided Surgery and Digital
Laparoscopy with the Senhance Surgical System here:
www.senhance.com. Now available for sale in the US, EU, Japan,
Russia, and select other countries. For a complete list of
indications for use, visit: www.senhance.com/indications. For more
information, visit www.asensus.com.
Forward-Looking Statements
This press release includes statements relating to the Senhance
Surgical System and Franklin Medical Center initiating a program
with the Senhance System. These statements and other statements
regarding our future plans and goals constitute "forward looking
statements" within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934, and
are intended to qualify for the safe harbor from liability
established by the Private Securities Litigation Reform Act of
1995. Such statements are subject to risks and uncertainties that
are often difficult to predict, are beyond our control and which
may cause results to differ materially from expectations and
include whether the Senhance Surgical System will improve surgical
outcomes at Franklin Medical Center and reduce the burden of
recovery upon Franklin Medical Center patients. For a discussion of
the risks and uncertainties associated with the Company’s business,
please review our filings with the Securities and Exchange
Commission (SEC), including our Annual Report on Form 10-K for the
year ended December 31, 2020, filed with the SEC on March 11, 2021
and our other filings we make with the SEC. You are cautioned not
to place undue reliance on these forward looking statements, which
are based on our expectations as of the date of this press release
and speak only as of the origination date of this press release. We
undertake no obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211115005326/en/
INVESTOR CONTACT: Mark Klausner or Mike Vallie,
443-213-0499 invest@asensus.com or MEDIA CONTACT: Kristin
Schaeffer, 858-354-8850 CG Life kschaeffer@cglife.com
Asensus Surgical, Inc. (NYSE:ASXC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Asensus Surgical, Inc. (NYSE:ASXC)
Historical Stock Chart
From Jan 2024 to Jan 2025